Literature DB >> 9661048

Receptor expression, cytogenetic, and molecular analysis of six continuous human glioma cell lines.

C A Kruse1, M Varella-Garcia, B K Kleinschmidt-Demasters, G C Owens, E B Spector, H Fakhrai, E Savelieva, B C Liang.   

Abstract

Six human glioma cell lines were established from tissues obtained from five patients diagnosed with Kernohan grade IV glioblastoma multiforme and one from a patient with a grade II astrocytoma. One line was from a recurrent patient who had received prior therapy; the other lines were derived from patients at initial diagnosis and/or before cytoreductive therapies other than surgery were given. Considerable variability in phenotypic, karyotypic, and cell surface marker expression was displayed between the six human glioma cell lines. The karyotypes ranged from apparently normal (grade II astrocytoma) to those with complex rearrangements. Trisomy of chromosome 7 was the most common abnormality. The extensive cytogenetic and molecular characterization of these lines may facilitate their utilization in cellular and molecular biologic studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661048     DOI: 10.1007/s11626-998-0078-x

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.723


  45 in total

1.  Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.

Authors:  R Albarosa; B M Colombo; L Roz; I Magnani; B Pollo; N Cirenei; C Giani; A M Conti; S DiDonato; G Finocchiaro
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  Establishment and characterization of a human glioblastoma multiforme cell line.

Authors:  A Bakir; F Gezen; O Yildiz; A Ayhan; S Kahraman; C A Kruse; M Varella-Garcia; F Yildiz; A Kubar
Journal:  Cancer Genet Cytogenet       Date:  1998-05

3.  Polysomy of chromosome 7 is correlated with overexpression of the erbB oncogene in human glioblastoma cell lines.

Authors:  W Henn; N Blin; K D Zang
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

Review 4.  Cell adhesion molecules in neural histogenesis.

Authors:  G M Edelman
Journal:  Annu Rev Physiol       Date:  1986       Impact factor: 19.318

5.  Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.

Authors:  M Hermansson; M Nistér; C Betsholtz; C H Heldin; B Westermark; K Funa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  In vitro studies on the cell-mediated immune response to human brain tumors. II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack.

Authors:  C L Gately; L M Muul; M A Greenwood; S Papazoglou; S J Dick; P L Kornblith; B H Smith; M K Gately
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

7.  Loss of heterozygosity for alleles on chromosome 10 in human brain tumours.

Authors:  Z Ye; J K Qu; B T Darras
Journal:  Neurol Res       Date:  1993-02       Impact factor: 2.448

8.  Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects.

Authors:  A Fontana; H Hengartner; N de Tribolet; E Weber
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

9.  Heterogeneity of Genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas.

Authors:  D D Bigner; S H Bigner; J Pontén; B Westermark; M S Mahaley; E Ruoslahti; H Herschman; L F Eng; C J Wikstrand
Journal:  J Neuropathol Exp Neurol       Date:  1981-05       Impact factor: 3.685

10.  Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors.

Authors:  G Tallini; M Ladanyi; J Rosai; S C Jhanwar
Journal:  Cytogenet Cell Genet       Date:  1994
View more
  7 in total

1.  Immunophenotypic and ultrastructural validation of a new human glioblastoma cell line.

Authors:  André A Schenka; Camila M L Machado; Mariângela C Grippo; Luciano S Queiroz; Natália G M Schenka; Cristiano A Chagas; Liana Verinaud; Pierre Brousset; José Vassallo
Journal:  Cell Mol Neurobiol       Date:  2005-08       Impact factor: 5.046

2.  Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors.

Authors:  German G Gomez; Susana B Read; Lazaro E Gerschenson; Daniela Santoli; Adam Zweifach; Carol A Kruse
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

3.  Recombination and its roles in DNA repair, cellular immortalization and cancer.

Authors:  M A Shammas; R J Shmookler Reis
Journal:  Age (Omaha)       Date:  1999-04

4.  Glioma cell integrin expression and their interactions with integrin antagonists: Research Article.

Authors:  Ralph-Heiko Mattern; Susana B Read; Michael D Pierschbacher; Chun-I Sze; Brian P Eliceiri; Carol A Kruse
Journal:  Cancer Ther       Date:  2005

5.  Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization.

Authors:  German G Gomez; Marileila Varella-Garcia; Carol A Kruse
Journal:  Cancer Genet Cytogenet       Date:  2006-03

Review 6.  In vivo models of primary brain tumors: pitfalls and perspectives.

Authors:  Peter C Huszthy; Inderjit Daphu; Simone P Niclou; Daniel Stieber; Janice M Nigro; Per Ø Sakariassen; Hrvoje Miletic; Frits Thorsen; Rolf Bjerkvig
Journal:  Neuro Oncol       Date:  2012-06-07       Impact factor: 12.300

7.  Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro.

Authors:  Camila M L Machado; Rafael Y Ikemori; Tatiana Q Zorzeto; Ana C M A Nogueira; Suse D S Barbosa; Wilson Savino; André A Schenka; José Vassallo; Juliana K Heinrich; Fátima Boetcher-Luiz; Liana Verinaud
Journal:  BMC Cancer       Date:  2008-10-08       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.